FDA has a Bioresearch Monitoring (BIMO) program and the BIMO program is managed by the Office of Scientific Investigations (OSI).
BIMO program is a comprehensive, FDA-wide program of on-site inspections and data audits, designed to monitor all aspects of the conduct and reporting of FDA-regulated research.
Objectives of the BIMO program includes:
- Protect the rights, safety, and welfare of human research subjects
- Verify the accuracy, reliability, and integrity of clinical and non-clinical trial data submitted to FDA
- Assess compliance with FDA's regulations governing the conduct of clinical and non-clinical trials, including regulations for informed consent and ethical review
The BIMO program also takes part in pharmacovigilance activities for postmarketing drug products. These activities serve to detect, understand, and prevent drug-related problems.
The BIMO program is managed and executed differently at different review centers (namely CDER and CBER). CBER's BIMO program was described in a FDA presentation by Dr Triet Tran "The Center for Biological Evaluation and Research (CBER) Bioresearch Monitoring (BIMO) Program". CDER's BIMO program was described in a Youtube video by Dr Kelly Nolen "Center for Drug Evaluation and Research (CDER) Bioresearch Monitoring (BIMO) Program - A General Overview".
For NDA or BLA submissions to CDER, sponsors are often asked to provide site-specific information to support the FDA’s Bioresearch Monitoring (BIMO) program and aid in selecting sites for inspection. The FDA typically includes standard language about this (see below) in their communications, such as in letters to the sponsor or the minutes of pre-NDA or pre-BLA meetings.
OFFICE OF SCIENTIFIC INVESTIGATIONS (OSI) REQUESTSSponsor's statistical programming group will need to prepare the BIMO related data sets and data listings - all by sites.
The Office of Scientific Investigations (OSI) requests that the items described in the draft guidance for industry, Standardized Format for Electronic Submission of NDA and BLA Content for the Planning of Bioresearch Monitoring (BIMO) Inspections for CDER Submissions, and the associated conformance guide, Bioresearch Monitoring Technical Conformance Guide Containing Technical Specifications, be provided to facilitate development of clinical investigator and sponsor/monitor/CRO inspection assignments, and the background packages that are sent with those assignments to the FDA ORA
investigators who conduct those inspections. This information is requested for all major trials used to support safety and efficacy in the application (i.e., phase 2/3 pivotal trials). Please note that if the requested items are provided elsewhere in submission in the format described, the Applicant can describe location or provide a link to the requested information.
Please refer to the draft guidance for industry Standardized Format for Electronic Submission of NDA and BLA Content for the Planning of Bioresearch Monitoring (BIMO) Inspections for CDER Submissions (February 2018) and the associated Bioresearch Monitoring Technical Conformance Guide Containing Technical Specifications.
- A data set containing general study related information and comprehensive clinical investigator information
- Subject level data listing by site
- Site level dataset
Details about BIMO datasets and data listings can be found in the FDA CDER guidance titled Bioresearch Monitoring Technical Conformance Guide Containing Technical Specifications (see the table of contents below). It’s important to note that this guidance applies only to CDER and not to other FDA review divisions like CBER. Since the BIMO technical conformance guide is regularly updated, the statistical programming team must ensure they are following the most current version when preparing the BIMO package for NDA or BLA submissions.
- BIMO Package: Challenges and Perspectives While Keeping Up with the Upgrades in the BIMO Technical Conformance Guide and the BDRG Guidelines
- BIMO SAS® Macros and Programming Tools
- Development of standard BIMO process to create clinsite dataset
- Preparing a Successful BIMO Data Package
- Bioresearch Monitoring (BIMO) Data Reviewer’s Guide
No comments:
Post a Comment